Mark S. Dorreen
Impact in
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 10
- Oncology 15
- Colorectal Cancer Treatments and Studies 3
- Neutropenia and Cancer Infections 3
- Co-authors
- Tim Lister (7 shared papers)P. F. M. Wrigley (7 shared papers)A G Stansfeld (4 shared papers)John A. Habeshaw (2 shared papers)A. Eric Jones (2 shared papers)Mark T. Fox (1 shared paper)T. Younis (2 shared papers)Pedro López (2 shared papers)
- Journals
- British Journal of Cancer (4 papers)Clinical Oncology (2 papers)Hematological Oncology (2 papers)European Journal of Cancer (2 papers)QJM (1 paper)
- Partner nations
- United KingdomCanada
In The Last Decade
Mark S. Dorreen
27 papers receiving 396 citations
Peers
Comparison fields: 5 of 55
- Pathology and Forensic Medicine 173
- Genetics 72
- Oncology 157
- Immunology 79
- Hematology 35
Countries citing papers authored by Mark S. Dorreen
This map shows the geographic impact of Mark S. Dorreen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Dorreen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Dorreen more than expected).
Fields of papers citing papers by Mark S. Dorreen
This network shows the impact of papers produced by Mark S. Dorreen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Dorreen. The network helps show where Mark S. Dorreen may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark S. Dorreen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 60 | |
| 2 | 1992 | 38 | |
| 3 | 1997 | 36 | |
| 4 | 1983 | 35 | |
| 5 | 1982 | 32 | |
| 6 | 1992 | 28 | |
| 7 | 2013 | 26 | |
| 8 | 1984 | 24 | |
| 9 | 1984 | 21 | |
| 10 | 1998 | 19 | |
| 11 | 1991 | 18 | |
| 12 | 1986 | 14 | |
| 13 | 1988 | 12 | |
| 14 | 2014 | 10 | |
| 15 | 1984 | 9 | |
| 16 | 2012 | 9 | |
| 17 | 1992 | 8 | |
| 18 | 2016 | 7 | |
| 19 | 1993 | 6 | |
| 20 | 1988 | 6 |
About Mark S. Dorreen
Mark S. Dorreen is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Pulmonary and Respiratory Medicine and Rheumatology, having authored 28 papers that have together received 439 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (4 papers), Lung Cancer Treatments and Mutations (4 papers), Gastric Cancer Management and Outcomes (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Multiple and Secondary Primary Cancers (3 papers) and Neutropenia and Cancer Infections (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (173 citations), Genetics (72 citations), Oncology (157 citations), Immunology (79 citations) and Hematology (35 citations). Mark S. Dorreen has collaborated with scholars based in United Kingdom and Canada. Frequent co-authors include Tim Lister, P. F. M. Wrigley, A G Stansfeld, John A. Habeshaw, A. Eric Jones, Mark T. Fox, T. Younis, Pedro López, Colin J. Germond and Stefan Glück. Their work appears in journals such as British Journal of Cancer, Clinical Oncology, Hematological Oncology, European Journal of Cancer and QJM.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.